We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$414M
AUM Growth
+$32.3M
(+8.5%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
30.48%
Holding
216
New
11
Increased
89
Reduced
59
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.36M |
| 2 |
NOV
NOV
|
+$1.18M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$936K |
| 4 |
Visa
V
|
+$812K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$805K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$501K |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$380K |
| 3 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$326K |
| 4 |
Liberty Global Class A
LBTYA
|
+$282K |
| 5 |
Biogen
BIIB
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.03% |
| 2 | Miscellaneous | 15.33% |
| 3 | Financials | 12.38% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Stryker
SYK
$127B
| $595K | 0.14% |
7,300
-50
| -0.7% | -$3.98K |
|
102
Sysco
SYY
$39.3B
| $593K | 0.14% |
16,413
-400
| -2% | -$14.4K |
|
|
MCR
103
DELISTED
MFS Charter Income Trust
MCR
| $586K | 0.14% |
64,200
| – | – |
|
104
National Grid
NGG
$79.8B
| $572K | 0.14% |
8,629
+311
| +4% | +$20K |
|
105
American Express
AXP
$225B
| $565K | 0.14% |
6,271
+3
| +0% | +$268 |
|
106
Invesco Value Municipal Income Trust
IIM
$601M
| $564K | 0.14% |
39,138
-2,880
| -7% | -$40.7K |
|
107
iShares MSCI Germany ETF
EWG
$1.74B
| $557K | 0.13% |
17,777
+1,400
| +9% | +$43.2K |
|
108
Halliburton
HAL
$30.1B
| $547K | 0.13% |
9,285
+125
| +1% | +$6.68K |
|
109
Allstate
ALL
$65.9B
| $539K | 0.13% |
9,520
+150
| +2% | +$8.05K |
|
|
SE
110
DELISTED
Spectra Energy Corp Wi
SE
| $529K | 0.13% |
14,316
| – | – |
|
111
Medtronic
MDT
$117B
| $506K | 0.12% |
8,219
-500
| -6% | -$29.1K |
|
112
American Electric Power
AEP
$66.6B
| $499K | 0.12% |
9,842
-2,021
| -17% | -$98.2K |
|
113
Phillips 66
PSX
$97.4B
| $499K | 0.12% |
6,470
+150
| +2% | +$11.4K |
|
114
Genuine Parts
GPC
$19B
| $467K | 0.11% |
5,375
| – | – |
|
115
Honeywell
HON
$68.9B
| $461K | 0.11% |
5,529
-165
| -3% | -$13.7K |
|
116
Travelers Companies
TRV
$77.2B
| $455K | 0.11% |
5,348
-4
| -0.1% | -$336 |
|
117
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $447K | 0.11% |
24,600
| – | – |
|
|
KRFT
118
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $447K | 0.11% |
7,973
-1,279
| -14% | -$69.5K |
|
119
Canadian National Railway
CNI
$76.2B
| $439K | 0.11% |
7,800
| – | – |
|
|
STI
120
DELISTED
SunTrust Banks, Inc.
STI
| $438K | 0.11% |
11,000
| – | – |
|
|
APC
121
DELISTED
Anadarko Petroleum
APC
| $434K | 0.1% |
5,124
-50
| -1% | -$4.1K |
|
|
ANZ
122
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
| $418K | 0.1% |
13,675
+2,500
| +22% | +$76.4K |
|
123
Cedar Fair
FUN
$1.66B
| $413K | 0.1% |
8,100
| – | – |
|
|
MMP
124
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $404K | 0.1% |
+5,800
| New | +$386K |
|
|
BHI
125
DELISTED
Baker Hughes
BHI
| $402K | 0.1% |
6,185
-510
| -8% | -$30.2K |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, M&R Capital Management held 216 positions worth $414M, up 8.5% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&R Capital Management deployed $27.9M of net new capital in Q1 2014, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $501K trimmed.
- M&R Capital Management's largest Q1 2014 buy was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
- M&R Capital Management added most to Allergan plc in Q1 2014, an estimated $8.36M increase.
- M&R Capital Management's biggest Q1 2014 reduction was Philip Morris, cutting an estimated $501K.
- M&R Capital Management fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $380K.
- M&R Capital Management's ten largest holdings make up 30% of its $414M portfolio in Q1 2014.
- M&R Capital Management opened 11 new positions and closed 8 in Q1 2014.
- M&R Capital Management's portfolio value rose 8.5% quarter-over-quarter to $414M.
Based on M&R Capital Management's 13F filing for Q1 2014, filed 2 May 2014.